Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis
- PMID: 26814969
- DOI: 10.1038/nature16543
Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis
Erratum for
-
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.Nature. 2008 Aug 7;454(7205):776-9. doi: 10.1038/nature07091. Epub 2008 Jun 25. Nature. 2008. PMID: 18594509 Free PMC article.
Similar articles
-
Editorial Expression of Concern: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis.Nature. 2025 May;641(8062):E6. doi: 10.1038/s41586-025-09026-7. Nature. 2025. PMID: 40275109 No abstract available.
-
Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.Biochem J. 2000 Sep 1;350 Pt 2(Pt 2):353-9. Biochem J. 2000. PMID: 10947948 Free PMC article.
-
Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.Cell Motil Cytoskeleton. 2004 Nov;59(3):180-8. doi: 10.1002/cm.20032. Cell Motil Cytoskeleton. 2004. PMID: 15468162
-
PI 3-Kinase p110β regulation of platelet integrin α(IIb)β3.Curr Top Microbiol Immunol. 2010;346:203-24. doi: 10.1007/82_2010_61. Curr Top Microbiol Immunol. 2010. PMID: 20517720 Review.
-
Ras, PI(3)K and mTOR signalling controls tumour cell growth.Nature. 2006 May 25;441(7092):424-30. doi: 10.1038/nature04869. Nature. 2006. PMID: 16724053 Review.
Cited by
-
PI3Kβ inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells.Oncol Rep. 2019 Jan;41(1):125-132. doi: 10.3892/or.2018.6845. Epub 2018 Nov 2. Oncol Rep. 2019. PMID: 30542720 Free PMC article.
-
Chemical Oral Cancerogenesis Is Impaired in PI3Kγ Knockout and Kinase-Dead Mice.Cancers (Basel). 2021 Aug 21;13(16):4211. doi: 10.3390/cancers13164211. Cancers (Basel). 2021. PMID: 34439365 Free PMC article.
-
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.Clin Cancer Res. 2019 Nov 1;25(21):6346-6356. doi: 10.1158/1078-0432.CCR-18-4032. Epub 2019 Jun 7. Clin Cancer Res. 2019. PMID: 31175097 Free PMC article.
References
-
- Nature. 2008 Aug 7;454(7205):776-9 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous